CHRONIC SPONTANEOUS URTICARIA
Clinical trials for CHRONIC SPONTANEOUS URTICARIA explained in plain language.
Never miss a new study
Get alerted when new CHRONIC SPONTANEOUS URTICARIA trials appear
Sign up with your email to follow new studies for CHRONIC SPONTANEOUS URTICARIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for stubborn hives: drug shows promise in blood pressure safety study
Disease control CompletedThis study tested a drug called remibrutinib in 144 adults with chronic spontaneous urticaria (long-term hives) that don't get better with standard allergy pills. The main goal was to check if the drug affects blood pressure over 12 weeks, while also seeing if it helps control hi…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 05:50 UTC
-
New hope for stubborn hives: experimental drug shows promise
Disease control CompletedThis study tested an experimental drug called povorcitinib in 136 adults with chronic spontaneous urticaria (long-term hives and itching) that standard antihistamines couldn't control. Participants took the drug or a placebo for 12 weeks to see if it reduced their hive and itch s…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
New shot offers hope for stubborn hives sufferers
Symptom relief CompletedThis study tested an experimental drug called LP-003 in 202 adults with chronic spontaneous urticaria (long-lasting hives and itching) that standard antihistamines couldn't fully control. Participants received injections of LP-003 or a placebo alongside their usual antihistamines…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE2 • Sponsor: Longbio Pharma • Aim: Symptom relief
Last updated May 26, 2026 06:00 UTC
-
New shot may ease itchy hives in teens
Symptom relief CompletedThis study tested a drug called ligelizumab in 49 teens aged 12 to 18 with chronic spontaneous urticaria (long-lasting hives with no clear trigger). The goal was to see if adding ligelizumab to standard antihistamines could reduce itching and welts better than a placebo. Particip…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated May 22, 2026 13:53 UTC
-
New hope for kids with stubborn hives: dupilumab study shows promise
Symptom relief CompletedThis study looked at how dupilumab works in children aged 2 to 12 with chronic spontaneous urticaria (CSU), a condition causing itchy hives and swelling that doesn't get better with standard allergy medicines. Fifteen children received dupilumab injections for 24 weeks, and resea…
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE3 • Sponsor: Sanofi • Aim: Symptom relief
Last updated May 22, 2026 13:50 UTC
-
New hope for teens with stubborn hives: xolair study shows promise
Symptom relief CompletedThis study looked at whether Xolair (omalizumab) is safe and effective for Chinese teenagers with chronic spontaneous urticaria (long-lasting hives and itching) that don't get better with standard antihistamines. Fifty-five teens took part, receiving Xolair for 12 weeks and then …
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated May 15, 2026 11:55 UTC
-
New hives drug tested in healthy volunteers for first time
Knowledge-focused CompletedThis early-stage study tested a new drug called LP-003 in 60 healthy adults to see if it is safe and how the body processes it. The study had two parts: one group got a single dose, another got multiple doses. The goal was to check for side effects and measure drug levels in the …
Matched conditions: CHRONIC SPONTANEOUS URTICARIA
Phase: PHASE1 • Sponsor: Longbio Pharma • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC